JP4581331B2 - Drug-filled multi-chamber bag - Google Patents

Drug-filled multi-chamber bag Download PDF

Info

Publication number
JP4581331B2
JP4581331B2 JP2003082699A JP2003082699A JP4581331B2 JP 4581331 B2 JP4581331 B2 JP 4581331B2 JP 2003082699 A JP2003082699 A JP 2003082699A JP 2003082699 A JP2003082699 A JP 2003082699A JP 4581331 B2 JP4581331 B2 JP 4581331B2
Authority
JP
Japan
Prior art keywords
chamber
storage chamber
medicine
drug
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003082699A
Other languages
Japanese (ja)
Other versions
JP2004290218A (en
Inventor
耕司 梅北
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP2003082699A priority Critical patent/JP4581331B2/en
Publication of JP2004290218A publication Critical patent/JP2004290218A/en
Application granted granted Critical
Publication of JP4581331B2 publication Critical patent/JP4581331B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/002Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means

Description

【0001】
【発明の属する技術分野】
本発明は、医療用液体、例えば、静脈投与用輸液剤、液状栄養剤、腹膜透析液等、に配合される複数有効成分を分離して保持し、投与直前にそれら複数有効成分を容易に混合することができる薬剤入り多室バッグに関する。
【0002】
【従来の技術】
従来、薬剤や栄養剤を収容保存するため、熱可塑性樹脂製容器やガラス容器が利用される。注射剤、静脈投与用輸液、透析溶液、点眼剤、眼科用灌流液及び臓器保存液等の医療用溶液は、容器にほぼ液密に充填され、殺菌又は滅菌される。これらの製品形態のひとつにキット製品があり上市されている。キット製品は、薬剤と医療用具又は2つ以上の薬剤をひとつの投与体系として組み合わせたものであり、医療機関における投薬調剤時の負担軽減、細菌汚染防止、異物混入防止等を目的とする。キット製品の事例は、予充填式使い捨て注射剤(プレフィルドシリンジ製品)、ダブルバッグと呼ばれる2室混合式輸液剤、例えば味の素ファルマ社製の「ピーエヌツイン」(商品名)等である。キット製品は、調剤時の過誤防止、緊急時の迅速な対応を可能にする等の利点を備える。
【0003】
ダブルバッグやプレフィルドシリンジは、容器を2室に区画したものが上市されているが、追加の薬剤や栄養剤等を加える場合に対応できない欠点があった。この問題を解決するために、3室を備える医療用容器が、例えば特許文献に提案されている。特許文献1の発明では、可撓性バッグを剥離可能なシールで区画し、第3の薬剤を収容する室を設けている。しかしながら多区画の部屋を備えた場合、確実にすべての区画を連通させ各成分を混合するには、極めて慎重な開通操作が必要となり、緊急時の迅速対応には問題がある。また、開通しない区画が残ったまま患者に投与された場合は、投与可能な液性とは異なる溶液が供給され副作用発現につながる問題がある。
【0004】
特許文献2は、液体薬剤を収納する第1の容器と固体薬剤を収納する第2の容器を一体化した複室輸液容器を開示する。この複室輸液容器は、第1の容器と第2の容器との間に仕切り部材30を備え、仕切り部材は、隣接する第1及び第2の容器を連通可能に接続する中空部、及びこの中空部の一端を封止する蓋体32を有する。蓋体32は、薄肉部を介して仕切り部材30の本体に連結され、仕切り部材を変形操作することにより開蓋される。この複室輸液容器は、少量の複数の薬剤を分離収納するができない短所を有する。輸液を初めとする医療用溶液は、投与する患者の病態に応じて、抗生物質やビタミン類を配合して使用する場合がある。また、各種の有効成分を複数の室に分離収容することで保存安定性の向上が期待できるものの、容器を複数に区画もしくは分室を設けることは、容器の製造工程が複雑となり、また使用の際の便宜性が低下するなどの問題を有する。
【0005】
【特許文献1】
特表2000−501324号公報
【特許文献2】
特開2000−87350号公報
【0006】
【発明が解決しようとする課題】
本発明の目的は、かかる現状に鑑み、現在、必要性が増大している3種以上の薬剤を容器内で簡易に混合することが可能な薬剤入り多室バッグを提供することである。また本発明の目的は、比較的多量の薬液を袋状容器に収容し比較的少量の複数の薬剤を多数の少容量の薬剤収容室に収容する薬剤のキット製品を提供することである。更に本発明の目的は、薬液収容室と薬剤収容室の間を弱シール部により仕切り、容器の外部から袋状容器内の薬液に押圧力を加えることにより薬液収容室と薬剤収容室の間の弱シール部を剥離させ薬液収容室と各薬剤収容室の間を液体連通状態にすることができ、緊急性を要する場合においても、簡易に誤りなく他室容器薬剤を混合可能な薬剤封入容器セットを提供することである。
【0007】
本発明の他の目的は、可撓性容器に収容された輸液に複数の薬剤収容室内の複数の少量の薬剤を無菌状態を保持したまま混合することができる薬剤入り多室バッグを提供することである。また本発明の目的は、薬剤入り多室バッグに収容された複数の薬剤を一回の操作により同時に無菌的に薬剤を混合することができる薬剤入り多室バッグを提供することである。更に本発明の目的は、多室バッグ内の薬液を中空針等を介して点滴チューブへ流出させ又は多室バッグ内へ中空針を介し追加の薬液を注入可能とするためのポート部材を提供することである。本発明のその他の目的及び利点は、図面及び以下の説明において明かにされる。
【0008】
【課題を解決するための手段】
本発明の薬剤入り多室バッグは、薬液を収容する第1及び第2薬液収容室、並びに薬剤を収容する薬剤収容室を有する。第1薬液収容室及び第2薬液収容室は、端縁部及び側縁部において結合される第1及び第2樹脂フィルムからなる袋状容器内にそれぞれ液体密封可能に形成される。第1及び第2薬液収容室の間に開口を備える箱部材が配置され、箱部材の開口の周囲部分と第1樹脂フィルムの間が弱シール部により接着される。弱シール部は第1収容室又は第2収容室内の薬液に容器外部から押圧力を加えることにより剥離されて開口の周囲部分と第1樹脂フィルムが離間される。
【0009】
薬剤収容室は、前記開口に連通され箱部材内に液体密封可能に形成され、前記弱シール部が剥離されると、薬剤収容室、第1収容室及び第2収容室が連通されて各収容室の薬液及び薬剤が混合される。前記箱部材は、複数の開口及び複数の薬剤収容室を有する。弱シール部は、第1収容室又は第2収容室内の薬液に容器外部から押圧力を加えることにより剥離されて開口の周囲部分と第1フィルムが離間され、前記弱シール部が剥離されるとき、第1収容室、第2収容室及び各薬剤収容室が連通されて各収容室の薬液及び薬剤が混合される。
【0010】
本発明の薬剤入り多室バッグは、ポート部材を含む。ポート部材は、中空針を刺通することができるゴム栓を備えて薬液収容室へ薬液を注入可能又は薬液収容室から薬液を抽出可能に構成され、且つ袋状容器の端縁部に配置される。前記ポート部材は、筒体及び保持具を備え、筒体及び保持具並びに容器本体の内壁面は、いずれもVICAT軟化点が121℃以上のプロピレン・α−オレフィンランダム共重合体により形成される。
【0011】
本発明のポート部材は、薬剤入り多室バッグを形成する袋状容器の端縁部に装着される。薬剤入り多室バッグは、それぞれ薬液が収容される第1薬液収容室及び第2薬液収容室を含む。ポート部材は、ゴム栓、筒体、及び保持具を含む。ゴム栓は中空針により刺通可能であり、ゴム栓を刺通する中空針を介し容器本体内の液体を注出又は容器本体内へ液体を注入することが可能である。筒体は、容器本体内部に配置される内方端、容器本体を形成する樹脂フィルムに液密に接着される外周面、ゴム栓に係合する外方端、及び保持具を支持する鍔部を有する。
【0012】
保持具は、環状の天板部分、及び天板部分外周から下方へ伸長する円筒部分、円筒部分の端部に形成される突条部分を有する。突条部分の先端が鍔部に設けた環状の凹部接触され、突条部分の先端と環状の凹部が溶着される。好ましくは、突条部分の先端と環状の凹部は、超音波エネルギーにより加熱溶着される。ゴム栓の周囲部分が筒体の上端部と保持具の間に挟持される。
【0013】
ゴム栓は、外方端付近の中空部を閉鎖する円板部分、円板部分の外周部から下方へ伸長する内方環状垂下部、外方端付近の筒体内周面に嵌合する外周面、外周面から半径方向外方へ伸長する環状板部、環状板部の外周から垂下する外方環状垂下部、環状板部の外周から上方へ伸長する外方環状凸部、外周面と外方環状垂下部の間に形成される下方環状溝、円板部分の外方と外方環状凸部との間に形成される上方環状溝を有する。
【0014】
本発明の多室バッグに収容される薬剤の事例は、経中心静脈栄養療法の開始液や維持液として使用できる高カロリー輸液用の糖・電解質・アミノ酸液にビタミン類を加えた輸液製剤である。この場合、糖・電解質・アミノ酸液は、薬液収容室に収容され、ビタミン類は、2以上の薬剤収容室に収容され、好ましい輸液製剤の態様となる。高カロリー輸液用ビタミン類は、ビタミンB1、ビタミンB2、ビタミンB6、ビタミンB12、ビタミンC、ビタミンA、ビタミンD、ビタミンE、ビタミンK、ビタミンH、葉酸、パントテン酸類、ニコチン酸類であり、これらは、配合変化させることなく安定に保存するために2以上の薬剤収容室に互いに分離され、且つ高カロリー輸液成分とも分離して収容される。
【0015】
高カロリー輸液用糖・電解質・アミノ酸液と同様な成分が配合された、末梢静脈あるいは腋窩静脈投与用輸液についても本発明の多室バッグを利用しビタミン類等の薬剤を収容し得る。前述の各輸液にビタミン類を配合するほか、鉄、マンガン、銅、亜鉛及びヨウ素の各供給源が配合された微量元素製剤(商品名 エレメンミック注、エレメイト注、味の素ファルマ社製)をビタミン類と分離して収容することも好ましい薬剤の組合せである。
【0016】
本発明の多室バッグは、安定剤や保存剤の減量もしくは省略を目的として各種薬剤の充填容器として使用できる。例えば、少なくとも必須アミノ酸であるL-トリプトファン、L-メチオニン、L-リジン、L-フェニルアラニン、L-ロイシン、L-イソロイシン、L-バリン、L-スレオニンを含むアミノ酸輸液(例えば、味の素ファルマ社製の商品名アミニック)には、保存安定性に問題のあるL-トリプトファンやL-システインが配合されており亜硫酸塩等の安定化剤が添加されている。L-トリプトファンとL-システインはそれぞれ安定に保存可能な液性を持つ溶液に溶解し、他のアミノ酸類と分離して多室バッグ収容することによりアミノ酸間の配合変化を起すことなく保存できることから安定剤の減量もしくは省略が可能となる。
【0017】
高カロリー輸液用糖・電解質・アミノ酸液に、注射用の消化性潰瘍剤、例えば、塩酸ラニチジン、塩酸ロキサチジン、シメチジン、ファモチジンなどのH2遮断剤や、肝臓障害用剤、例えば、グリチルリチン、グリシン、システインを混合使用可能にするため、それらを本発明の多室バッグに収容することができる。本発明の多室バッグは、混注可能な導入手段と連通する空室に消化性潰瘍剤や肝臓障害溶剤を注入することにより、在宅高カロリー輸液療法用の薬剤入り容器とすることができる。
【0018】
【発明の実施の態様】
図1は、本発明の第1実施例の薬剤入り多室バッグを示す概略平面図、図2は、図1の多室バッグに組込まれる箱部材の概略端面図である。図1に示すように、薬剤入り多室バッグ1は、薬液M1、M2を収容する薬液収容室4、ポート部材3、及び薬剤N1、N2、N3を収容する複数の薬剤収容室61、62、63を有する。薬液収容室4は、袋状容器2内に形成される。袋状容器2は、2枚の樹脂フィルムを端縁部23、24、側縁部25、25において相互に接着して形成される。
【0019】
ポート部材3は、中空針を刺通可能なゴム栓33を備え、薬液収容室4へ薬液を注入可能又は薬液収容室4から薬液を抽出可能に構成される。図1、図3及び図5の実施例において、薬液収容室4は、弱シール部44により区画される第1収容室41及び第2収容室42から成る。、弱シール部44は、第1収容室41内の薬液M1又は第2収容室42内の薬液M2に容器外部から押圧力を加えることにより剥離し、第1収容室と第2収容室を連通させる。ポート部材3は、袋状容器2の上方及び下方の端縁部23、24にそれぞれ1個ずつ配置される。
【0020】
複数の薬剤収容室61、62、63は、袋状容器2の一方の端縁部23に配置される箱部材5の内部に形成される。箱部材5は、各薬剤収容室61、62、63の壁面部分を形成する蓋部材55を有する。蓋部材55は、箱部材55が変形されないとき各薬剤収容室61、62、63を薬液収容室4に対して密封状態に区画し、箱部材5が外部から変形力を受け変形することにより開放位置へ移動し薬剤収容室61、62、63を薬液収容室4と流体連通させる。
【0021】
複数の薬剤収容室61、62、63は、それぞれ別々に密封可能にされ、蓋部材55が開放位置へ移動されたとき、薬剤収容室61、62、63のそれぞれが薬液収容室4と連通される。複数の薬剤収容室61、62、63は、図2に示すように、それぞれ薬液注入ポート51、52、53を有する。この薬液注入ポート51、52、53を介し必要に応じ、追加の薬液が各薬剤収容室61、62、63へ注入される。
【0022】
図1の多室バッグ1は、第1収容室41及び第2収容室42にそれぞれ輸液成分を収容し、各薬剤収容室61、62、63にそれぞれ薬剤N1、N2、N3を収容する。薬剤N1、N2、N3は、例えばビタミン、ミネラル、その他の薬剤である。輸液を投与する際、箱部材5が容器外部から人手で変形され、蓋部材55が開放され、各薬剤収容室と第1収容室41が連通され、各薬剤収容室61、62、63内の薬剤が、第1収容室の薬液M1に混合される。
【0023】
第1収容室41又は第2収容室42の一方又は両方に外部から圧力を加えることにより、弱シール部66が剥離される。弱シール部66が剥離されると、第1収容室41、第2収容室42、各薬剤収容室61、62、63が相互に連通する。それにより薬液M1とM2が混合されると共に、各薬剤収容室61、62、63内の薬剤N1、N2、N3が薬液M1とM2と混合される。薬液M1とM2及び薬剤N1、N2、N3が混合された混合薬液は、第2収容室側の薬液注入抽出ポート3を介する中空針、輸液チューブ(図示しない)等を経て患者へ供給される。多室バッグ1は、縁部23のほぼ中央に吊下げ孔25を備える。輸液投与の際、多室バッグ1は、吊下げ孔25を利用し、所定高さ位置に吊下げられる。
【0024】
本発明の袋状容器2、箱部材6等は、熱可塑性樹脂で構成される。この熱可塑性樹脂は、耐熱性、機械的強度、柔軟性、耐薬品性、とりわけ成形加工性、ガスバリア性、耐屈曲性、透明性、紫外線遮蔽性などについて収容する薬剤や栄養剤に適した樹脂とされる。袋状容器2は、単層構造あるいは二層以上の積層構造の熱可塑性樹脂フィルムにより形成することができる。熱可塑性樹脂としては、1種または2種以上のものを混合して用いることができる。また分子鎖に官能基を導入し、変性した熱可塑性樹脂も用いられる。
【0025】
袋状容器2を形成する熱可塑性樹脂は、例えばポリエチレン、ポリプロピレン、エチレン−α−オレフィン共重合体のごときポリオレフィン、ポリスチレン、ポリカーボネート、ポリエチレンテレフタレートやポリブチレンテレフタレートのごときポリエステル、ポリアセタール、ポリアミド、ポリフェニレンエーテル、ポリエーテルサルホン、ポリサルホン、エチレン−酢酸ビニル共重合体、ポリ塩化ビニル、ポリ塩化ビニリデン、ポリフェニレンサルファイド、フッ素樹脂、アクリル樹脂、環状ポリオレフィンなどである。これらの中でも、ポリエチレン、ポリプロピレン、エチレン−α−オレフィン共重合体、ポリエチレンテレフタレートが好ましい。
【0026】
薬剤収容室61、62、63は、薬剤の吸着が少ない樹脂で構成されることが好ましく、そのような樹脂としてはポリエチレンナフタレート、環状ポリオレフィン、エチレン-テトラフルオロエチレン共重合体、ポリエーテルサルホン及びポリサルホンを挙げることができる。前記3種類の樹脂薬剤との接触面に設ける構成とするのがよい。
【0027】
発明の多室バッグを形成するフィルム又はシートの表面には、必要に応じて表面処理を施すことができる。このような表面処理法としては、例えばコロナ放電処理、プラズマ処理、火炎処理、スパッタリング処理、溶剤処理、紫外線処理、赤外線処理、オゾン処理、研摩処理などが挙げられる。容器本体を形成するフィルムを積層構造体とする場合は、必要に応じて各層の間にホットメルト接着剤、ポリウレタン接着剤などを使用して各層間の接着強度を向上させることも可能である。
【0028】
図6乃至図9を参照し、ポート部材3の実施例を説明する。ポート部材3は、図1に示すように薬剤入り多室バッグ1を形成する袋状容器の端縁部24に装着される。ポート部材3は、ゴム栓80、筒体30、及び保持具70を含む。ゴム栓80は図示しない中空針により刺通可能であり、ゴム栓80を刺通する中空針を介し容器本体内の液体を注出又は容器本体内へ液体を注入することが可能である。筒体30は、容器本体内部に配置される内方端31、容器本体を形成する樹脂フィルムに液密に接着される外周面35、ゴム栓80に係合する外方端36、及び保持具70を支持する鍔部32を有する。
【0029】
保持具70は、環状の天板部分71、及び天板部分の外周から下方へ伸長する円筒部分72、円筒部分の端部に形成される突条部分73を有する。突条部分73の先端が鍔部32に設けた環状凹部33に接触され、突条部分73の先端と環状凹部33が溶着される。好ましくは、突条部分73の先端と環状凹部33は、超音波エネルギーにより加熱溶着される。ゴム栓80の周囲部分が筒体30の外方端36と保持具70との間に挟持される。
【0030】
ゴム栓80は、外方端36付近の中空部を閉鎖する円板部分81、円板部分の外周部から下方へ伸長する内方環状垂下部82、外方端36付近の筒体内周面34に嵌合する外周面83、外周面83から半径方向外方へ伸長する環状板部84、環状板部84の外周から垂下する外方環状垂下部86、環状板部84の外周から上方へ伸長する外方環状凸部87、外周面83と外方環状垂下部86の間に形成される下方環状溝85、円板部分81の外方と外方環状凸部87との間に形成される上方環状溝88を有する。
【0031】
図9は、保持具70、筒体30及びゴム栓80を組合わせたポート部材3の概略断面図である。ゴム栓80は、筒体30の上方開口を閉鎖し、筒体30の外方端36と保持具70の間に挟持される。保持具70は、その突条部分73の先端と筒体30の環状凹部33が溶着されることにより、筒体30に固定される。ゴム栓80及び保持具70の外面は、保護キャップ90により覆われる。ポート部材を介し袋状容器内の薬液を注出する場合、保護キャップ90を外し、ゴム栓80の円板部分81を横断するように中空針を刺通し、中空針を通し薬液を注出することができる。円板部分81の外面は保護キャップ90を外すまで清浄に保たれる。
【0032】
【発明の効果】
本発明の薬剤入り多室バッグは、複数の薬剤収容室を開口を備える箱部材に設け、箱部材を第1薬液収容室と第2薬液収容室の間に配置し、箱部材の開口の周囲部分と袋状容器を形成する第1樹脂フィルムが弱シール部により接着され、薬剤の投与に際し、容器外方から人手により力を加えることにより弱シール部を剥離させ、第1薬液収容室、第2薬液収容室及び複数の薬剤収容室を相互に連通させるので、1回の操作で複数の薬液及び薬剤を容器内で無菌状態で混合させることができる。また、本発明の薬剤入り多室バッグは、複数の薬液及び薬剤を外気に晒すことなく分離状態で保管するので、外気中の酸素による変化や薬液の混合変化を生じることを防ぐことができる。そして使用に際しては、複数の室に収容された薬剤を短い時間で容易に無菌状態で誤動作なく混合することができる。
【0033】
本発明において、筒体の鍔部に設けた上方環状溝と保持具の突条部分とが超音波振動エネルギーにより加熱溶着され、溶着部が形成され、筒体の鍔部と保持具の間が強固に連結される。それ故、袋状容器が薬液を収容し滅菌のため高圧室内で例えば20分間121℃に維持されポート部材のゴム栓に容器内から比較的大きな圧力が作用する場合にも、ゴム栓は、保持具によりしっかり押圧され、抜出すことがない。また、上方環状溝と保持具の突条部分との間のに形成される溶着部は、ポート部材の外部から視認可能であるので溶着部の検査が容易である。
【図面の簡単な説明】
【図1】本発明の第1実施例の薬剤入り多室バッグを示す概略平面図。
【図2】図1の線T−Tに沿う概略断面図。
【図3】図1の線S−Sに沿う概略断面図。
【図4】本発明の薬剤入り多室バッグに組込まれる箱部材の概略斜視図。
【図5】本発明の薬剤入り多室バッグに組込まれる箱部材の開口側から見た概略斜視図。
【図6】本発明の実施例のポート部材の保持具の概略断面図。
【図7】ポート部材の実施例の筒体の概略断面図。
【図8】ポート部材の実施例のゴム栓の概略断面図。
【図9】ポート部材の実施例の保持具、筒体及びゴム栓を組合わせた概略断面図。
【符号の説明】
G1、G2:気体、M1、M2:薬液、N1、N2、N3:薬剤、1:多室バッグ、2:容器本体、3:ポート部材、6:箱部材、21:第1樹脂フィルム、22:第2樹脂フィルム、23、24:端縁部、25:側縁部、27:強シール部、29:吊り下げ孔、30:筒体、31:内方端、32:鍔部、33:環状凹部、34:内周面、35:外周面、36:外方端、41:第1薬液収容室、42:第2薬液収容室、60:箱部材、61、62、63:薬剤収容室、65、651、652、653:開口、66、661、662、663:弱シール部、67、671、672、673:箱部材外周面、68、69:箱部材の端面、70:保持具、71:天板部分、72:円筒部分、73:突条部分、74天板内周面、75:環状凸部、80:ゴム栓、81:円板部分、82:内方環状垂下部、83:外周面、84:環状板部、85:下方環状溝、86:外方環状垂下部、87:外方環状凸部、88:上方環状溝、90:保護キャップ。
[0001]
BACKGROUND OF THE INVENTION
The present invention separates and holds a plurality of active ingredients blended in a medical fluid such as an intravenous infusion, a liquid nutrient, a peritoneal dialysis solution, etc., and easily mixes the plurality of active ingredients immediately before administration. about the drug-filled multi-chamber back grayed that can be.
[0002]
[Prior art]
Conventionally, a container made of a thermoplastic resin or a glass container is used in order to store and store medicines and nutrients. Medical solutions such as injections, infusion solutions for intravenous administration, dialysis solutions, eye drops, ophthalmic perfusates and organ preservation solutions are almost liquid-tightly filled and sterilized or sterilized. One of these product forms is a kit product that is on the market. The kit product is a combination of a drug and a medical device or two or more drugs as a single administration system, and is intended to reduce the burden at the time of dispensing in a medical institution, prevent bacterial contamination, and prevent foreign substances from being mixed. Examples of kit products are prefilled disposable injections (prefilled syringe products), two-chamber mixed-type infusions called double bags, such as “PN Twin” (trade name) manufactured by Ajinomoto Pharma. The kit product has advantages such as prevention of errors during dispensing and quick response in an emergency.
[0003]
Double bags and prefilled syringes are commercially available with two containers divided into compartments, but have the disadvantage of not being able to cope with the addition of additional drugs or nutrients. In order to solve this problem, a medical container including three chambers has been proposed in, for example, patent literature. In the invention of Patent Document 1, a flexible bag is partitioned by a peelable seal, and a chamber for storing a third medicine is provided. However, when a multi-compartment room is provided, an extremely careful opening operation is required to ensure communication between all the compartments and mixing of the components, and there is a problem in quick response in an emergency. Moreover, when it is administered to a patient with a section that is not opened, a solution different from the administrable liquid property being supplied, leading to the occurrence of side effects.
[0004]
Patent Document 2 discloses a multi-chamber infusion container in which a first container for storing a liquid drug and a second container for storing a solid drug are integrated. The multi-chamber infusion container includes a partition member 30 between the first container and the second container, and the partition member includes a hollow portion that connects the adjacent first and second containers so that they can communicate with each other. It has the cover body 32 which seals one end of a hollow part. The lid body 32 is connected to the main body of the partition member 30 via a thin portion, and is opened by deforming the partition member. This multi-chamber infusion container has a disadvantage that a small amount of a plurality of drugs cannot be separated and stored. In some cases, medical solutions such as infusions are mixed with antibiotics and vitamins depending on the pathology of the patient to whom they are administered. In addition, storage stability can be expected to be improved by separating and storing various active ingredients in multiple chambers. However, providing multiple compartments or compartments for the container complicates the manufacturing process of the container, and can be used during use. There is a problem that convenience of the service is reduced.
[0005]
[Patent Document 1]
JP 2000-501324 A [Patent Document 2]
Japanese Patent Laid-Open No. 2000-87350
[Problems to be solved by the invention]
In view of the current situation, an object of the present invention is to provide a multi-chamber bag containing medicines that can be easily mixed in a container with three or more kinds of medicines that are currently in increasing demand. Another object of the present invention is to provide a drug kit product that stores a relatively large amount of drug solution in a bag-like container and stores a relatively small amount of a plurality of drugs in a large number of small-volume drug storage chambers. Further, an object of the present invention is to partition the drug solution storage chamber and the drug storage chamber by a weak seal portion, and apply a pressing force to the drug solution in the bag-like container from the outside of the container, thereby providing a space between the drug solution storage chamber and the drug storage chamber. A drug-filled container set that can peel the weak seal part and make the liquid communication state between the drug solution storage chamber and each drug storage chamber, and can easily mix the containers in other chambers even when urgent is required Is to provide.
[0007]
Another object of the present invention is to provide a drug-containing multi-chamber bag capable of mixing a plurality of small amounts of drugs in a plurality of drug storage chambers while maintaining aseptic conditions with an infusion contained in a flexible container. It is. Another object of the present invention is to provide a drug-containing multi-chamber bag capable of simultaneously aseptically mixing a plurality of drugs contained in a drug-containing multi-chamber bag by a single operation. Furthermore, an object of the present invention is to provide a port member for allowing a chemical solution in a multi-chamber bag to flow out to an infusion tube via a hollow needle or the like, or allowing an additional chemical solution to be injected into the multi-chamber bag via a hollow needle. That is. Other objects and advantages of the present invention will become apparent in the drawings and the following description.
[0008]
[Means for Solving the Problems]
The multi-chamber bag containing medicines of the present invention has first and second chemical solution storage chambers for storing a chemical solution, and a drug storage chamber for storing a drug. The first chemical solution storage chamber and the second chemical solution storage chamber are formed in a bag-like container composed of first and second resin films that are joined at the end edge portion and the side edge portion, respectively, so as to be liquid-tight. A box member having an opening is disposed between the first and second chemical solution storage chambers, and a portion between the opening of the box member and the first resin film is bonded by a weak seal portion. The weak seal portion is peeled off by applying a pressing force from the outside of the container to the chemical solution in the first storage chamber or the second storage chamber, and the peripheral portion of the opening is separated from the first resin film.
[0009]
The drug storage chamber communicates with the opening and is formed in a box member so as to be liquid-tight. When the weak seal portion is peeled off, the drug storage chamber, the first storage chamber, and the second storage chamber communicate with each other. The chamber solution and drug are mixed. The box member has a plurality of openings and a plurality of medicine storage chambers. The weak seal portion is peeled off by applying a pressing force from the outside of the container to the chemical solution in the first storage chamber or the second storage chamber, the peripheral portion of the opening is separated from the first film, and the weak seal portion is peeled off The first storage chamber, the second storage chamber, and the respective drug storage chambers are communicated to mix the chemical solution and the drug in each of the storage chambers.
[0010]
The drug-containing multi-chamber bag of the present invention includes a port member. The port member has a rubber stopper that can pierce a hollow needle, is configured to be able to inject a chemical solution into the chemical solution storage chamber, or to be able to extract a chemical solution from the chemical solution storage chamber, and is disposed at the edge of the bag-like container. The The port member includes a cylinder and a holder, and the cylinder, the holder, and the inner wall surface of the container body are all formed of a propylene / α-olefin random copolymer having a VICAT softening point of 121 ° C. or higher.
[0011]
The port member of the present invention is attached to the edge of a bag-like container forming a multi-chamber bag containing medicine. The multi-chamber bag containing medicine includes a first chemical solution storage chamber and a second chemical solution storage chamber in which chemical solutions are respectively stored. The port member includes a rubber plug, a cylinder, and a holder. The rubber stopper can be pierced by a hollow needle, and the liquid in the container body can be poured out or injected into the container body through the hollow needle that pierces the rubber stopper. The cylindrical body has an inner end disposed inside the container body, an outer peripheral surface that is liquid-tightly bonded to the resin film forming the container body, an outer end that engages with the rubber stopper, and a collar portion that supports the holder. Have
[0012]
The holder has an annular top plate portion, a cylindrical portion extending downward from the outer periphery of the top plate portion, and a protruding portion formed at an end of the cylindrical portion. The tip of the ridge is brought into contact with an annular recess provided in the collar, and the tip of the ridge and the annular recess are welded. Preferably, the tip of the ridge portion and the annular recess are heat-welded by ultrasonic energy. A peripheral portion of the rubber stopper is sandwiched between the upper end portion of the cylindrical body and the holder.
[0013]
The rubber plug has a disc portion that closes the hollow portion near the outer end, an inner annular hanging portion that extends downward from the outer periphery of the disc portion, and an outer peripheral surface that fits into the cylindrical peripheral surface near the outer end. , An annular plate portion extending radially outward from the outer peripheral surface, an outer annular hanging portion depending from the outer periphery of the annular plate portion, an outer annular convex portion extending upward from the outer periphery of the annular plate portion, and the outer peripheral surface and outward A lower annular groove formed between the annular hanging portions and an upper annular groove formed between the outer side of the disk portion and the outer annular convex portion are provided.
[0014]
Examples of drugs contained in the multi-chamber bag of the present invention are infusion preparations in which vitamins are added to sugar / electrolyte / amino acid solutions for high-calorie infusions that can be used as starting solutions and maintenance solutions for transcentral parenteral nutrition therapy . In this case, the sugar / electrolyte / amino acid solution is accommodated in the drug solution storage chamber, and the vitamins are stored in two or more drug storage chambers. Vitamins for high calorie infusion are vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, vitamin A, vitamin D, vitamin E, vitamin K, vitamin H, folic acid, pantothenic acids, nicotinic acids, In order to stably store the composition without changing the composition, it is separated from each other in two or more drug storage chambers and separated from the high-calorie infusion component.
[0015]
The peripheral vein or axillary vein infusion containing the same components as the high calorie infusion sugar, electrolyte, and amino acid solution can also contain drugs such as vitamins using the multi-chamber bag of the present invention. In addition to blending vitamins in each of the aforementioned infusions, trace element preparations (trade names: Elemental Note, Elemate Note, Ajinomoto Pharma Co., Ltd.) containing each source of iron, manganese, copper, zinc, and iodine vitamins It is also a preferred combination of drugs to be housed separately.
[0016]
The multi-chamber bag of the present invention can be used as a filling container for various drugs for the purpose of reducing or omitting stabilizers and preservatives. For example, an amino acid infusion containing at least the essential amino acids L-tryptophan, L-methionine, L-lysine, L-phenylalanine, L-leucine, L-isoleucine, L-valine, L-threonine (for example, manufactured by Ajinomoto Pharma) (Trade name Aminic) contains L-tryptophan and L-cysteine, which have a problem in storage stability, and is added with a stabilizer such as sulfite. L-tryptophan and L-cysteine are each dissolved in a liquid solution that can be stored stably, separated from other amino acids, and stored in a multi-chamber bag so that they can be stored without causing changes in the composition between amino acids. It is possible to reduce or omit the stabilizer.
[0017]
High calorie infusion sugar / electrolyte / amino acid solution, peptic ulcer for injection, for example, ranitidine hydrochloride, roxatidine hydrochloride, cimetidine, famotidine and other H 2 blockers, and liver damage agents such as glycyrrhizin, glycine, In order to be able to mix cysteine, they can be accommodated in the multi-chamber bag of the present invention. The multi-chamber bag of the present invention can be used as a drug-containing container for home high-calorie infusion therapy by injecting a peptic ulcer agent or a liver injury solvent into an empty room communicating with a co-injectable introduction means.
[0018]
BEST MODE FOR CARRYING OUT THE INVENTION
FIG. 1 is a schematic plan view showing a drug-containing multi-chamber bag according to a first embodiment of the present invention, and FIG. 2 is a schematic end view of a box member incorporated in the multi-chamber bag of FIG. As shown in FIG. 1, a multi-chamber bag 1 containing medicines includes a chemical solution storage chamber 4 that stores chemical solutions M1 and M2, a port member 3, and a plurality of drug storage chambers 61 and 62 that store drugs N1, N2, and N3. 63. The chemical solution storage chamber 4 is formed in the bag-like container 2. The bag-like container 2 is formed by bonding two resin films to each other at the end edge portions 23 and 24 and the side edge portions 25 and 25.
[0019]
The port member 3 includes a rubber stopper 33 that can be pierced with a hollow needle, and is configured to be able to inject a chemical solution into the chemical solution storage chamber 4 or to extract a chemical solution from the chemical solution storage chamber 4. In the embodiment shown in FIGS. 1, 3, and 5, the chemical solution storage chamber 4 includes a first storage chamber 41 and a second storage chamber 42 defined by a weak seal portion 44. The weak seal portion 44 is peeled off by applying a pressing force from the outside of the container to the chemical solution M1 in the first storage chamber 41 or the chemical solution M2 in the second storage chamber 42, and communicates the first storage chamber and the second storage chamber. Let One port member 3 is disposed at each of the upper and lower edge portions 23 and 24 of the bag-like container 2.
[0020]
The plurality of medicine storage chambers 61, 62, 63 are formed inside the box member 5 disposed at one end edge 23 of the bag-like container 2. The box member 5 includes a lid member 55 that forms a wall surface portion of each medicine storage chamber 61, 62, 63. When the box member 55 is not deformed, the lid member 55 partitions the drug storage chambers 61, 62, and 63 in a sealed state with respect to the drug solution storage chamber 4, and the box member 5 receives the deformation force from the outside and deforms to open. The drug storage chambers 61, 62, 63 are in fluid communication with the drug solution storage chamber 4.
[0021]
The plurality of drug storage chambers 61, 62, 63 can be sealed separately, and when the lid member 55 is moved to the open position, each of the drug storage chambers 61, 62, 63 communicates with the drug solution storage chamber 4. The The plurality of drug storage chambers 61, 62, 63 have drug solution injection ports 51, 52, 53, respectively, as shown in FIG. Additional chemical solutions are injected into the respective drug storage chambers 61, 62, and 63 as necessary through the chemical solution injection ports 51, 52, and 53.
[0022]
The multi-chamber bag 1 of FIG. 1 stores the infusion component in the first storage chamber 41 and the second storage chamber 42, respectively, and stores the drugs N1, N2, and N3 in the drug storage chambers 61, 62, and 63, respectively. The drugs N1, N2, and N3 are vitamins, minerals, and other drugs, for example. When administering the infusion, the box member 5 is manually deformed from the outside of the container, the lid member 55 is opened, the drug storage chambers communicate with the first storage chamber 41, and the drug storage chambers 61, 62, 63 The medicine is mixed with the chemical liquid M1 in the first storage chamber.
[0023]
By applying pressure from the outside to one or both of the first storage chamber 41 and the second storage chamber 42, the weak seal portion 66 is peeled off. When the weak seal portion 66 is peeled off, the first storage chamber 41, the second storage chamber 42, and the drug storage chambers 61, 62, 63 communicate with each other. As a result, the drug solutions M1 and M2 are mixed, and the drugs N1, N2, and N3 in the drug storage chambers 61, 62, and 63 are mixed with the drug solutions M1 and M2. The mixed drug solution in which the drug solutions M1 and M2 and the drugs N1, N2, and N3 are mixed is supplied to the patient via a hollow needle, an infusion tube (not shown), and the like through the drug solution injection and extraction port 3 on the second storage chamber side. The multi-chamber bag 1 is provided with a hanging hole 25 substantially at the center of the edge 23. At the time of infusion administration, the multi-chamber bag 1 is suspended at a predetermined height position using the suspension holes 25.
[0024]
The bag-like container 2 and the box member 6 of the present invention are made of a thermoplastic resin. This thermoplastic resin is suitable for chemicals and nutrients that contain heat resistance, mechanical strength, flexibility, chemical resistance, especially moldability, gas barrier properties, flex resistance, transparency, and UV shielding properties. It is said. The bag-like container 2 can be formed of a thermoplastic resin film having a single layer structure or a laminated structure of two or more layers. As the thermoplastic resin, one kind or a mixture of two or more kinds can be used. A thermoplastic resin modified by introducing a functional group into the molecular chain is also used.
[0025]
The thermoplastic resin forming the bag-shaped container 2 is, for example, polyolefin such as polyethylene, polypropylene, ethylene-α-olefin copolymer, polystyrene, polycarbonate, polyester such as polyethylene terephthalate or polybutylene terephthalate, polyacetal, polyamide, polyphenylene ether, Polyethersulfone, polysulfone, ethylene-vinyl acetate copolymer, polyvinyl chloride, polyvinylidene chloride, polyphenylene sulfide, fluororesin, acrylic resin, cyclic polyolefin and the like. Among these, polyethylene, polypropylene, ethylene-α-olefin copolymer, and polyethylene terephthalate are preferable.
[0026]
The drug storage chambers 61, 62, and 63 are preferably made of a resin with low drug adsorption. Examples of such resins include polyethylene naphthalate, cyclic polyolefin, ethylene-tetrafluoroethylene copolymer, and polyethersulfone. And polysulfone. It is good to set it as the structure provided in a contact surface with the said 3 types of resin chemical | medical agents.
[0027]
The surface of the film or sheet forming the multi-chamber bag of the invention can be subjected to surface treatment as necessary. Examples of such surface treatment methods include corona discharge treatment, plasma treatment, flame treatment, sputtering treatment, solvent treatment, ultraviolet treatment, infrared treatment, ozone treatment, and polishing treatment. When the film forming the container body is a laminated structure, it is possible to improve the adhesive strength between the layers by using a hot melt adhesive, a polyurethane adhesive or the like between the layers as necessary.
[0028]
An embodiment of the port member 3 will be described with reference to FIGS. As shown in FIG. 1, the port member 3 is attached to the edge 24 of the bag-like container that forms the multi-chamber bag 1 containing a medicine. The port member 3 includes a rubber plug 80, a cylindrical body 30, and a holder 70. The rubber stopper 80 can be pierced by a hollow needle (not shown), and the liquid in the container body can be poured out or injected into the container body through the hollow needle that pierces the rubber stopper 80. The cylindrical body 30 includes an inner end 31 disposed inside the container main body, an outer peripheral surface 35 that is liquid-tightly bonded to a resin film forming the container main body, an outer end 36 that engages with the rubber plug 80, and a holder. 70 has a flange 32 for supporting 70.
[0029]
The holder 70 has an annular top plate portion 71, a cylindrical portion 72 extending downward from the outer periphery of the top plate portion, and a ridge portion 73 formed at the end of the cylindrical portion. The tip of the ridge portion 73 is brought into contact with the annular recess 33 provided in the flange portion 32, and the tip of the ridge portion 73 and the annular recess 33 are welded. Preferably, the tip of the protrusion 73 and the annular recess 33 are heat-welded with ultrasonic energy. A peripheral portion of the rubber plug 80 is sandwiched between the outer end 36 of the cylindrical body 30 and the holder 70.
[0030]
The rubber plug 80 includes a disc portion 81 that closes a hollow portion near the outer end 36, an inner annular hanging portion 82 that extends downward from the outer peripheral portion of the disc portion, and a cylindrical peripheral surface 34 near the outer end 36. The outer peripheral surface 83 fitted to the outer peripheral surface 83, the annular plate portion 84 extending radially outward from the outer peripheral surface 83, the outer annular hanging portion 86 depending from the outer periphery of the annular plate portion 84, and the upward extending from the outer periphery of the annular plate portion 84. An outer annular projection 87, a lower annular groove 85 formed between the outer circumferential surface 83 and the outer annular hanging portion 86, and an outer annular projection 87 formed between the outer side of the disk portion 81 and the outer annular projection 87. It has an upper annular groove 88.
[0031]
FIG. 9 is a schematic cross-sectional view of the port member 3 in which the holder 70, the cylindrical body 30, and the rubber plug 80 are combined. The rubber plug 80 closes the upper opening of the cylinder 30 and is sandwiched between the outer end 36 of the cylinder 30 and the holder 70. The holder 70 is fixed to the cylindrical body 30 by welding the tip of the protrusion 73 and the annular recess 33 of the cylindrical body 30. The outer surfaces of the rubber plug 80 and the holder 70 are covered with a protective cap 90. When the chemical solution in the bag-like container is poured out through the port member, the protective cap 90 is removed, the hollow needle is pierced so as to cross the disc portion 81 of the rubber plug 80, and the chemical solution is poured out through the hollow needle. Can do. The outer surface of the disc portion 81 is kept clean until the protective cap 90 is removed.
[0032]
【The invention's effect】
The multi-chamber bag with medicine of the present invention is provided with a plurality of medicine storage chambers in a box member having an opening, the box member is disposed between the first chemical solution storage chamber and the second chemical solution storage chamber, and the periphery of the opening of the box member The first resin film forming the portion and the bag-like container is bonded by the weak seal portion, and when administering the drug, the weak seal portion is peeled off by applying force manually from the outside of the container, and the first chemical solution storage chamber, Since the two drug solution storage chambers and the plurality of drug storage chambers communicate with each other, a plurality of drug solutions and drugs can be mixed aseptically in the container by one operation. In addition, since the multi-chamber bag containing medicines of the present invention is stored in a separated state without exposing a plurality of medicines and medicines to the outside air, it is possible to prevent changes due to oxygen in the outside air and changes in the mixture of medicines. In use, the medicines stored in a plurality of chambers can be easily mixed in a sterile state without malfunction in a short time.
[0033]
In the present invention, the upper annular groove provided in the flange portion of the cylindrical body and the protruding portion of the holder are heat-welded by ultrasonic vibration energy to form a welded portion, and the gap between the flange portion of the cylindrical body and the holder is formed. Strongly connected. Therefore, even when a bag-like container contains a chemical solution and is maintained at 121 ° C. for 20 minutes in a high-pressure chamber for sterilization and a relatively large pressure acts on the rubber stopper of the port member from inside the container, the rubber stopper is retained. It is firmly pressed by the tool and does not come out. Moreover, since the welding part formed between an upper annular groove and the protrusion part of a holder is visible from the exterior of a port member, the test | inspection of a welding part is easy.
[Brief description of the drawings]
FIG. 1 is a schematic plan view showing a multi-chamber bag containing medicine according to a first embodiment of the present invention.
FIG. 2 is a schematic cross-sectional view taken along line TT in FIG.
3 is a schematic cross-sectional view taken along line SS in FIG.
FIG. 4 is a schematic perspective view of a box member incorporated in the multi-chamber bag containing medicine according to the present invention.
FIG. 5 is a schematic perspective view seen from the opening side of a box member incorporated in the multi-chamber bag containing medicine according to the present invention.
FIG. 6 is a schematic cross-sectional view of a port member holder according to an embodiment of the present invention.
FIG. 7 is a schematic cross-sectional view of a cylindrical body of an embodiment of a port member.
FIG. 8 is a schematic cross-sectional view of a rubber plug of an embodiment of a port member.
FIG. 9 is a schematic cross-sectional view of a combination of a holder, a cylinder, and a rubber plug of an embodiment of a port member.
[Explanation of symbols]
G1, G2: Gas, M1, M2: Chemical solution, N1, N2, N3: Drug, 1: Multi-chamber bag, 2: Container body, 3: Port member, 6: Box member, 21: First resin film, 22: 2nd resin film, 23, 24: edge part, 25: side edge part, 27: strong seal part, 29: suspension hole, 30: cylinder, 31: inner end, 32: collar part, 33: annular Recess, 34: inner peripheral surface, 35: outer peripheral surface, 36: outer end, 41: first chemical solution storage chamber, 42: second chemical solution storage chamber, 60: box member, 61, 62, 63: drug storage chamber, 65, 651, 652, 653: Opening, 66, 661, 662, 663: Weak seal part, 67, 671, 672, 673: Outer surface of box member, 68, 69: End surface of box member, 70: Holder, 71 : Top plate portion, 72: cylindrical portion, 73: ridge portion, 74 inner peripheral surface of top plate, 75: annular convex portion, 80 Rubber stopper, 81: disc part, 82: inner annular hanging part, 83: outer peripheral surface, 84: annular plate part, 85: lower annular groove, 86: outer annular hanging part, 87: outer annular convex part, 88: Upper annular groove, 90: Protective cap.

Claims (3)

薬液を収容する第1及び第2薬液収容室、並びに薬剤を収容する薬剤収容室を有する薬剤入り多室バッグであって、
第1薬液収容室及び第2薬液収容室は、端縁部及び側縁部において結合される第1及び第2樹脂フィルムからなる袋状容器内にそれぞれ液体密封可能に形成され、両室の間に、複数の開口及び複数の薬剤収容室を備える箱部材が配置され、前記第1薬液収容室と前記第2薬液収容室は、前記箱部材を介して連接され、箱部材の各開口の周囲部分と第1樹脂フィルムの間が弱シール部により接着されて、前記箱部材の開口に対向する底部と第2樹脂フィルムの間が強シール部により接着され、前記開口に連通され箱部材内に液体密封可能に形成され、第1収容室又は第2収容室内の薬液に容器外部から押圧力を加えることにより弱シール部が剥離されて開口の周囲部分と第1樹脂フィルムが離間され、それにより薬剤収容室、第1収容室及び第2収容室が連通されて各収容室の薬液及び薬剤が混合される薬剤入り多室バッグ。
A multi-chamber bag containing a medicine having first and second medicine storage chambers for storing a medicine and a medicine storage chamber for storing a medicine,
The first chemical solution storage chamber and the second chemical solution storage chamber are formed in a bag-like container composed of the first and second resin films joined at the end edge portion and the side edge portion, respectively, so as to be liquid-tight, and between the two chambers. A box member having a plurality of openings and a plurality of drug storage chambers is disposed, and the first drug solution storage chamber and the second drug solution storage chamber are connected via the box member, and around each opening of the box member The portion and the first resin film are bonded by a weak seal portion, and the bottom portion facing the opening of the box member and the second resin film are bonded by a strong seal portion, communicated with the opening and in the box member The liquid seal is formed so that the weak seal portion is peeled off by applying a pressing force from the outside of the container to the chemical solution in the first storage chamber or the second storage chamber, thereby separating the peripheral portion of the opening and the first resin film, thereby Medicine storage chamber, first storage chamber and first storage chamber Medicated multi-chamber bag accommodating chamber chemical and agents each accommodation chamber is communicated with are mixed.
請求項1の薬剤入り多室バッグであって、袋状容器の端縁部に配置されるポート部材を含み、該ポート部材は、中空針を刺通することができるゴム栓を備えて薬液収容室へ薬液を注入可能又は薬液収容室から薬液を抽出可能に構成される薬剤入り多室バッグ。  The multi-chamber bag containing a medicine according to claim 1, comprising a port member disposed at an edge of the bag-like container, the port member including a rubber stopper capable of penetrating a hollow needle and containing a chemical solution A multi-chamber bag containing a medicine configured to be able to inject a medicine into a chamber or to extract a medicine from a medicine storage chamber. 請求項2の薬剤入り多室バッグであって、前記ポート部材は筒体及び保持具を含み、筒体及び保持具並びに容器本体の内壁面は、いずれもVICAT軟化点が121℃以上のプロピレン・α−オレフィンランダム共重合体により形成される薬剤入り多室バッグ。  The multi-chamber bag containing a medicine according to claim 2, wherein the port member includes a cylinder and a holder, and the inner wall of the cylinder and the holder and the container main body each have a propensity of 121 ° C or higher for a VICAT softening point. A multi-chamber bag containing a drug formed of an α-olefin random copolymer.
JP2003082699A 2003-03-25 2003-03-25 Drug-filled multi-chamber bag Expired - Fee Related JP4581331B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003082699A JP4581331B2 (en) 2003-03-25 2003-03-25 Drug-filled multi-chamber bag

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003082699A JP4581331B2 (en) 2003-03-25 2003-03-25 Drug-filled multi-chamber bag

Publications (2)

Publication Number Publication Date
JP2004290218A JP2004290218A (en) 2004-10-21
JP4581331B2 true JP4581331B2 (en) 2010-11-17

Family

ID=33398382

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003082699A Expired - Fee Related JP4581331B2 (en) 2003-03-25 2003-03-25 Drug-filled multi-chamber bag

Country Status (1)

Country Link
JP (1) JP4581331B2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006198295A (en) * 2005-01-24 2006-08-03 Nikkiso Co Ltd Dialysis agent storing container
DE102011017048A1 (en) * 2011-04-14 2012-10-18 Fresenius Medical Care Deutschland Gmbh Multi-chamber container for the production of medical solutions
US20140219585A1 (en) * 2012-12-31 2014-08-07 LSG Sky Chefs Supply Chain Solutions, Inc. Multi-Chamber Bag
MY177573A (en) * 2014-01-08 2020-09-21 Otsuka Pharma Factory Inc Cap
CN113397972A (en) * 2014-12-18 2021-09-17 株式会社大冢制药工厂 Port and liquid medicine bag
JP6707521B2 (en) * 2015-03-26 2020-06-10 テルモ株式会社 Medical container
CN107539535A (en) * 2016-06-23 2018-01-05 上海东富龙科技股份有限公司 A kind of soft bag ultrasonic bonding closing device
CA3038173A1 (en) * 2016-09-28 2018-04-05 Fresenius Kabi Deutschland Gmbh Sealing cap for a container for holding a medical liquid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000005275A (en) * 1998-06-17 2000-01-11 Terumo Corp Container for supplying infusion
JP2002000702A (en) * 2000-06-20 2002-01-08 Ajinomoto Faruma Kk Resin-made container for enclosing medical liquid and port member
JP2002248158A (en) * 2000-10-13 2002-09-03 Material Eng Tech Lab Inc Medical container stored with article and container suitable for the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000005275A (en) * 1998-06-17 2000-01-11 Terumo Corp Container for supplying infusion
JP2002000702A (en) * 2000-06-20 2002-01-08 Ajinomoto Faruma Kk Resin-made container for enclosing medical liquid and port member
JP2002248158A (en) * 2000-10-13 2002-09-03 Material Eng Tech Lab Inc Medical container stored with article and container suitable for the same

Also Published As

Publication number Publication date
JP2004290218A (en) 2004-10-21

Similar Documents

Publication Publication Date Title
TWI586349B (en) Insert and vial for the infusion of liquids, vial-insert assembly for the infusion of liquids and method for transferring a liquid from a vial to another receptacle
WO2007114157A1 (en) Communicating member, medical container using the same, and infusion solution preparing tool set
JP4236131B2 (en) Medical container
JP2005523772A (en) Medical multi-chamber container and storage bag for storing the same
US7789852B2 (en) Medical liquid container and preparation-containing medical liquid container
US6773427B2 (en) Infusion container
JP4581331B2 (en) Drug-filled multi-chamber bag
JP4483037B2 (en) Resin container for enclosing medical liquid and port member
JP4920246B2 (en) Medical liquid container and medical liquid container with medicine
JP4452903B2 (en) Medical solution mixed solution bag
WO1999006089A1 (en) Medical container
JP4378966B2 (en) Multi-chamber drug container
JP4793558B2 (en) Multi-chamber storage container
KR20120087960A (en) Connector set for medical container
JP4575084B2 (en) Infusion container and method for producing infusion container
JP2004290217A (en) Multi-cell vessel containing medicine
JP2994417B2 (en) Medicine container
JP4822860B2 (en) Medical multi-chamber container
JP2001009006A (en) Double cell container
JP5376825B2 (en) Method of injecting chemical solution container, chemical formulation and medical solution into medical infusion bag
WO2002072175A1 (en) Chemical liquid injection port, and chemical liquid container having the same
JP2003104302A (en) Manufacturing method of bag for liquid
JP4594556B2 (en) Infusion container
JP4708248B2 (en) Medical container
JP2006255378A (en) Small capacity container

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20040917

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20040921

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20050524

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060209

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090224

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090427

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091124

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100224

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100622

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100709

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100803

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100816

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130910

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130910

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees